Results 221 to 230 of about 11,447,845 (407)
Polypharmacy and Drug-Drug Interaction Architecture in Hospitalized Cardiovascular Patients: Insights from Real-World Analysis. [PDF]
BiomedicinesRadu AF +9 more
europepmc +1 more source
Clinical Pharmacokinetics of Zanisamide and Drug Interaction with Other Anticonvulsants.
, 1994 Yoshio Ijiri +6 more
openalex +2 more sources
Drug–drug interaction potential in men treated with enzalutamide: Mind the gap
British Journal of Clinical Pharmacology, 2018 G. E. Benoist +7 more
semanticscholar +1 more source
Molecular Oncology, EarlyView.Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang +3 more
wiley +1 more source
Enhanced CYP2C19-mediated drug-drug interaction risk with escitalopram in geriatric populations. [PDF]
Front PharmacolByoun S +7 more
europepmc +1 more source
Molecular Oncology, EarlyView.Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee +8 more
wiley +1 more source
Drug-Drug Interaction Liabilities with BTK Inhibitor TL-895. [PDF]
Cancer Res CommunStromatt JC +10 more
europepmc +1 more source
Microstructural-Mechanical Interactions of Drug Coated Balloons
, 2019 Jesse Lauber +3 more
openalex +2 more sources